PROCEPT BioRobotics Corp (PRCT)
72.66
-1.65
(-2.22%)
USD |
NASDAQ |
Oct 04, 16:00
72.65
-0.01
(-0.01%)
After-Hours: 20:00
PROCEPT BioRobotics SG&A Expense (TTM): 149.61M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 149.61M |
March 31, 2024 | 141.24M |
December 31, 2023 | 131.77M |
September 30, 2023 | 121.49M |
June 30, 2023 | 113.36M |
March 31, 2023 | 100.57M |
December 31, 2022 | 88.83M |
Date | Value |
---|---|
September 30, 2022 | 79.06M |
June 30, 2022 | 66.43M |
March 31, 2022 | 59.07M |
December 31, 2021 | 51.04M |
September 30, 2021 | 43.90M |
June 30, 2021 | 38.84M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
38.84M
Minimum
Jun 2021
149.61M
Maximum
Jun 2024
91.17M
Average
88.83M
Median
Dec 2022
SG&A Expense (TTM) Benchmarks
Boston Scientific Corp | 5.431B |
Intuitive Surgical Inc | 2.036B |
Perspective Therapeutics Inc | 18.64M |
Xtant Medical Holdings Inc | 79.82M |
Catheter Precision Inc | 10.84M |